ArticleFrontiers in immunology2026

Case Report: Dupilumab as a steroid-sparing therapeutic option in refractory anti-p200 pemphigoid: real-world effectiveness in a patient with significant comorbidities.

Aikaterini Kyriakou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.